Provided by Tiger Trade Technology Pte. Ltd.

BAIYUNSHAN PH

15.740
-0.160-1.01%
Volume:190.00K
Turnover:2.99M
Market Cap:25.59B
PE:7.41
High:15.990
Open:15.990
Low:15.680
Close:15.900
52wk High:19.716
52wk Low:14.000
Shares:1.63B
HK Float Shares:219.90M
Volume Ratio:0.48
T/O Rate:0.09%
Dividend:0.96
Dividend Rate:6.07%
EPS(LYR):2.123
ROE:7.43%
ROA:2.37%
PB:0.56
PE(LYR):7.41
PS:0.28

Loading ...

BAIYUNSHAN PH's Subsidiary Receives Approval for Supplemental Applications of Cefuroxime Sodium and Candesartan Cilexetil Tablets

Stock News
·
May 11

Baiyunshan Pharma Tables 10 Director Nominations for Upcoming Three-Year Board Term

Bulletin Express
·
May 07

BAIYUNSHAN PH (00874) Proposes Director Re-election and New Appointments

Stock News
·
May 07

Baiyunshan Pharmaceutical Sets AGM for 29 May 2026; Agenda Covers 2025 Results, Profit Distribution and Tenth-Board Elections

Bulletin Express
·
May 07

Baiyunshan Pharma Sets 29 May AGM; Seeks RMB 64.12 Billion Credit Lines, Proposes Board Reshuffle and Auditor Re-appointment

Bulletin Express
·
May 07

BAIYUNSHAN PH Reports First-Quarter Net Profit of RMB 1.78 Billion, Down 2.06% Year-on-Year

Stock News
·
Apr 27

Guangzhou Baiyunshan Pharmaceutical - Qtrly Income From Operations RMB23.28 Bln

THOMSON REUTERS
·
Apr 27

白云山医药2025年收入达人民币77,656,109,939.23元,归母净利同比增长5.21%

Bulletin Express
·
Apr 22

Baiyunshan PH Adopts Full Electronic Dissemination of Corporate Communications

Bulletin Express
·
Apr 22

Baiyunshan Pharmaceutical Sets 27 April 2026 Board Meeting to Review Q1 2026 Unaudited Results

Bulletin Express
·
Apr 14

Revenue Growth Masks Cash Flow Crisis: Baiyunshan Faces Three Structural Risks

Deep News
·
Apr 03

JPMorgan Increases Stake in Baiyunshan by Approximately 143,900 Shares at HK$16.89 Per Share

Stock News
·
Apr 02

Baiyunshan Pharma Gets Approval for Carbocisteine Oral Solution's Registration in Macau

MT Newswires Live
·
Apr 02

Baiyunshan Pharmaceutical Gets Nod for Marketing Transfer of Bone Health Drug

MT Newswires Live
·
Apr 02

Baiyunshan Pharmaceutical Division Secures NMPA Approval for Calcitriol Soft Capsules

Stock News
·
Apr 01

Baiyunshan Pharma Reports No Changes to Share Capital in March 2026 Monthly Return

Bulletin Express
·
Apr 01

Domestic ED Drug Jinge's Sales Decline for Second Consecutive Year

Deep News
·
Mar 27

Baiyunshan Pharmaceutical Announces RMB0.45 Final Dividend for FY2025

Bulletin Express
·
Mar 20

BAIYUNSHAN PH (00874) Announces Final Dividend of HK$0.45 Per Share

Stock News
·
Mar 20

BAIYUNSHAN PH Reports Annual Results with 5.21% Increase in Net Profit

Stock News
·
Mar 20